Press release
Integrin Beta 3 Market - Pipeline Review, H1 2018: Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3
Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) pipeline Target constitutes close to 20 molecules. Out of which approximately 13 molecules are developed by companies and remaining by the universities/institutes. The latest report Integrin Beta 3 - Pipeline Review, H1 2018, outlays comprehensive information on the Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.
Get Sample Copy of this report @ https://www.marketresearchreports.biz/sample/sample/1532632
Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Integrin beta-3 (3) or CD61 is a protein that in humans is encoded by the ITGB3 gene. Integrin beta 3 is found along with the alpha IIb chain in platelets. It is a receptor for cytotactin, fibronectin, laminin, matrix metalloproteinase-2, osteopontin, osteomodulin, prothrombin, thrombospondin, vitronectin and von Willebrand factor. Activation of integrin alpha-IIb/beta-3 leads to platelet interaction through binding of soluble fibrinogen. This leads to rapid platelet aggregation which physically plugs ruptured endothelial surface. The molecules developed by companies in Phase II, IND/CTA Filed, Preclinical and Discovery stages are 3, 1, 8 and 1 respectively. Similarly, the universities portfolio in Preclinical stages comprises 7 molecules, respectively. Report covers products from therapy areas Oncology, Metabolic Disorders, Ophthalmology, Cardiovascular, Dermatology, Gastrointestinal and Infectious Disease which include indications Wet (Neovascular / Exudative) Macular Degeneration, Glioblastoma Multiforme (GBM), Breast Cancer, Diabetic Nephropathy, Diabetic Retinopathy, Melanoma, Arterial Thrombosis, Cardiovascular Disease, Diabetic Macular Edema, Ischemic Cerebral Stroke, Lung Cancer, Malabsorption Syndrome, Metastatic Melanoma, Multiple Myeloma (Kahler Disease), Myocardial Infarction, Pancreatic Cancer, Retinal Vein Occlusion, Sepsis and Venous Leg Ulcers (Crural ulcer).
Furthermore, this report also reviews key players involved in Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) targeted therapeutics development with respective active and dormant or discontinued projects. Driven by data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Browse Complete Report with TOC @
https://www.marketresearchreports.biz/reports/1532632/integrin-beta-3-platelet-membrane-glycoprotein-iiia-or-cd61-or-itgb3-pipeline-review-h1-2018-market-research-reports/toc
Scope
- The report provides a snapshot of the global therapeutic landscape for Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3)
- The report reviews Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) targeted therapeutics and enlists all their major and minor projects
- The report assesses Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) targeted therapeutics
Reasons to buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
View Sample PDF @ https://www.marketresearchreports.biz/reports/1532632/integrin-beta-3-platelet-membrane-glycoprotein-iiia-or-cd61-or-itgb3-pipeline-review-h1-2018-market-research-reports.pdf
About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Integrin Beta 3 Market - Pipeline Review, H1 2018: Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3 here
News-ID: 945786 • Views: …
More Releases from MarketResearchReports.biz
Hydro-flyers Market: Moving Towards a Brighter Future
A hydro-flyer is an adventure sporting device which uses the propulsion of water jet technology to create continuous flight movement, where the lift and movement are controlled by the flyer. Hydro-flyers sporting devices make use of the flow of water power to drive the flyer to reach soaring heights. The rise in water sporting facilities is one of the major factors that promote the growth and demand for hydro-flyers in…
Outdoor Floodlights: Technology and Market Dynamics
Outdoor floodlights is a reliable, highly efficient, and economical solution for a wide range of outdoor applications. These lights are resistant to temperature fluctuations and they remain stable even in extreme climatic conditions. Unlike the traditional lights, floodlights remain stable and functional even in harsh climatic conditions. This makes them ideal for use in any climate and any outdoor application. Outdoor floodlights save a significant amount of energy and consume…
Snow Helmets Market Future Prospects and Regional Outlook
Riders are riding faster and getting bolder day by day. Hence, safety equipment need to be updated as per the requirement and changing time. Earlier, helmets were primarily used by extreme skiers and racers. They were used only on slopes. However, later, the use of helmets was made compulsory. Earlier, bulky black helmets were used by riders, which are outdated at present. Currently, new stylish helmets that can match with…
Predictions for 2019: Global Sparkling Water Dispensers Industry Is Set to Boom
Sparkling water dispensers are equipment used for dispensing carbonated water. These dispensers mix the still, filtered water with carbon dioxide before dispensing. Sparkling water dispensers are mostly used in households and commercial establishments such as amusement parks, hotels, restaurants, and sports arenas. A sparkling water dispenser has separate outlets for hot water and cold water. The hot water outlet does not require a separate filtration process. However, cold water is…
More Releases for Integrin
Integrin Beta Market 2021 Size, Growth Analysis Report, Forecast to 2027
The global integrin beta market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Integrins are proteins that function mechanically. They attach to the cell cytoskeleton to the extracellular matrix (ECM), and biochemically through sensing if adhesion has occurred. The integrin family consists of two types of protein including alpha and beta subtypes. Additionally, there are 8 types of integrin beta-protein such as IGBT1, IGBT2, IGBT3,…
Human Integrin Beta 3 Market: Competitive Dynamics & Global Outlook 2020-2025
Human Integrin Beta 3
This report also researches and evaluates the impact of Covid-19 outbreak on the Human Integrin Beta 3 industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Human Integrin Beta 3 Maker and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market Overview
The Human Integrin Beta 3 Maker market report provides a detailed analysis of global market…
Human Integrin Beta 3 Market to Witness Robust Expansion by 2025
LP INFORMATION recently released a research report on the Human Integrin Beta 3 market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Human Integrin Beta 3market by key players, product type, applications and regions,etc.
The main objective of this market research is to help the readers understand the structure of Human Integrin Beta 3market, market definition,…
Integrin Beta3 Protein Market Size, Share, Development by 2025
LP INFORMATION recently released a research report on the Integrin Beta3 Protein market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Integrin Beta3 Proteinmarket by key players, product type, applications and regions,etc.
The main objective of this market research is to help the readers understand the structure of Integrin Beta3 Proteinmarket, market definition, overview, industry opportunities…
Human Integrin Beta3 Antibody Market: Competitive Dynamics & Global Outlook 2025
LP INFORMATION recently released a research report on the Human Integrin Beta3 Antibody market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Human Integrin Beta3 Antibodymarket by key players, product type, applications and regions,etc.
The main objective of this market research is to help the readers understand the structure of Human Integrin Beta3 Antibodymarket, market definition,…
Integrin Beta 3 Market To Observe Strong Development through H1 2018
Overview
Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) pipeline Target constitutes close to 20 molecules. Out of which approximately 13 molecules are developed by companies and remaining by the universities/institutes. The latest report Integrin Beta 3 - Pipeline Review, H1 2018, outlays comprehensive information on the Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) targeted therapeutics, complete with analysis by indications, stage of development,…
